Article Text

Download PDFPDF
Early and exclusive enteral nutrition in infants born very preterm
  1. Jacqueline Razzaghy,
  2. Vivek V Shukla,
  3. Emily Gunawan,
  4. Audrey Reeves,
  5. Kelly Nguyen,
  6. Ariel A Salas
  1. Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA
  1. Correspondence to Dr Ariel A Salas, The University of Alabama at Birmingham, Birmingham, AL 35233, USA; asalas{at}peds.uab.edu

Abstract

Objective To characterise the effects of early and exclusive enteral nutrition with either maternal or donor milk in infants born very preterm (280/7–326/7 weeks of gestation).

Design Parallel-group, unmasked randomised controlled trial.

Setting Regional, tertiary neonatal intensive care unit.

Participants 102 infants born very preterm between 2021 and 2022 (51 in each group).

Intervention Infants randomised to the intervention group received 60–80 mL/kg/day within the first 36 hours after birth. Infants randomised to the control group received 20–30 mL/kg/day (standard trophic feeding volumes).

Main outcome measures The primary outcome was the number of full enteral feeding days (>150 mL/kg/day) in the first 28 days after birth. Secondary outcomes included growth and body composition at the end of the first two postnatal weeks, and length of hospitalisation.

Results The mean birth weight was 1477 g (SD: 334). Half of the infants were male, and 44% were black. Early and exclusive enteral nutrition increased the number of full enteral feeding days (+2; 0–2 days; p=0.004), the fat-free mass-for-age z-scores at postnatal day 14 (+0.5; 0.1–1.0; p=0.02) and the length-for-age z-scores at the time of hospital discharge (+0.6; 0.2–1.0; p=0.002). Hospitalisation costs differed between groups (mean difference favouring the intervention group: −$28 754; −$647 to −$56 861; p=0.04).

Conclusions In infants born very preterm, early and exclusive enteral nutrition increases the number of full enteral feeding days. This feeding practice may also improve fat-free mass accretion, increase length and reduce hospitalisation costs.

Trial registration number NCT04337710.

  • Neonatology
  • Growth
  • Intensive Care Units, Neonatal

Data availability statement

Data are available upon reasonable request. Deidentified individual participant data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to asalas@uab.edu.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Deidentified individual participant data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to asalas@uab.edu.

View Full Text

Footnotes

  • JR and VVS contributed equally.

  • Funding AAS is supported by a research grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23HD102554) and the UAB Pittman Scholars Program.

  • Competing interests AAS has a patent for an instrumented feeding bottle. Additionally, AAS has provided scientific advice to Resbiotic, received consulting fees for participating in advisory board meetings for Reckitt/Mead Johnson Nutrition and received speaking fees for participating in educational activities organised by p-value communications and WebMD.

  • Provenance and peer review Not commissioned; externally peer reviewed.